Article Information
History
- September 29, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- 1Peking University Peoples Hospital, Peking University Institute of Hematology. National Clinical Research Center for Hematologic Disease, Beijing, China
- 2JC School of Public Health and Primary Care, Chinese University of Hong Kong, Hong Kong, SAR China
- 3Chinese lymphoma patients organization, House086, Beijing, China
- 4Haematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom
- 5Harbin Institute of Hematology & Oncology, Harbin, China
- ↵*Correspondence: huangxiaojun{at}bjmu.edu.cn, Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease. No. 11, Xizhimen Nan Street, Beijing, 100044, China.
Ma J and Huang XJ have the same contribution.